Maryam Paynemaryam.payne@bioinfoinc.comProstate CancerBio-Techne announces interim results on prostate test long-term studyIn the prospective, randomized study, researchers are assessing the clinical outcomes of 1,049 men ages 50 and over who have prostate specific antigen (PSA) in the gray zone of uncertain prostate cancer risk.May 18, 2023Diabetic NephropathyRenalytix announces review data on kidney disease risk assessment testA review of the data underscored the effectiveness of KidneyIntelX in identifying patients at greatest risk of decline into kidney failure at the earlier stages, when progression can be slowed.April 19, 2023HIVRoche, CDC expand partnership on HIV and TB support for healthcare systems in critical regionsThe public-private partnership, named Lab Networks for Health, aims to improve HIV and TB detection, prevention, and treatment in countries that have been hit hardest by the two diseases.February 28, 2023Research and DevelopmentMIT researchers record cellular memories through protein chainsThe protein chains can be imaged using a microscope, revealing cellular “memories,” shedding light on processes such as gene expression, drug treatment response, and memory formation.January 3, 2023CancerStudy reveals biomarkers associated with immune checkpoint inhibitor myocarditisMyocarditis during cancer treatment with an immune checkpoint inhibitor (ICI) was associated with increased levels of three biomarkers implicated in skeletal muscle damage.December 21, 2022Alzheimer'sBlood test in study detects proteins fundamental to dementia before symptoms developThe research team is working with scientists at AltPep, a University of Washington spinout company, to develop a soluble oligomer binding assay as a diagnostic test.December 5, 2022Alzheimer'sUrine biomarker may reveal early-stage Alzheimer’s disease, study showsA urine-based test for early Alzheimer’s detection would be inexpensive, noninvasive, widely accessible, and considerably easier to deploy in routine screening than current methods.November 30, 2022DiabetesWidespread HbA1c screening enables earlier type 2 diabetes diagnosis in U.K. studyHbA1c screening in adults between 40 and 70 years of age can reduce the time to diabetes diagnosis by a median of 2.2 years compared with routine clinical care, the authors found.November 22, 2022CancerLancet report on gaps in European cancer research calls for prioritization of prevention, early diagnosisA report published in Lancet Oncology found that an estimated 100 million cancer screening tests were missed during the first year of the COVID-19 pandemic.November 16, 2022Alzheimer'sAlzheimer’s study compares blood-based biomarkers, other detection technologiesThe Global Alzheimer’s Platform Foundation technology study, with more than 1,000 participants, focuses on access and diversity.November 15, 2022Page 1 of 2Next PageTop StoriesCancerInvivoscribe, Complete Genomics partner to develop NGS tests for cancer research, detectionUnder the terms of the deal, Invivoscribe will be responsible for the development of biomarker tests, including test controls and associated bioinformatics software. The tests will run on Complete Genomics' NGS platforms.Regulatory ApprovalSeegene obtains IVDR certification for 30 diagnostic assaysPolicy and RegulationAdvocacy groups in letter urge FDA to develop regulations for lab-developed testsCollaborationNucleai, Adlai Nortye collaborate on biomarkers for clinical trialsSponsor ContentVisit our Molecular Diagnostics Community
